​

LifeStance Health Group (LFST) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LFST Stock Forecast

LifeStance Health Group (LFST) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $9.30, with a high of $11.00 and a low of $8.00. This represents a 40.06% increase from the last price of $6.64.

$4 $5 $6 $7 $8 $9 $10 $11 High: $11 Avg: $9.3 Low: $8 Last Closed Price: $6.64

LFST Stock Rating

LifeStance Health Group stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (90.91%), 1 Hold (9.09%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 1 10 Strong Sell Sell Hold Buy Strong Buy

LFST Price Target Upside V Benchmarks

TypeNameUpside
StockLifeStance Health Group40.06%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks19.55%

Price Target Trends

1M3M12M
# Anlaysts147
Avg Price Target$10.00$9.63$9.29
Last Closing Price$6.64$6.64$6.64
Upside/Downside50.60%45.03%39.91%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26271--10
Feb, 26271--10
Jan, 26271--10
Dec, 25171--9
Nov, 25141--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 25, 2026BMO Capital$10.00$7.4134.95%50.60%
Feb 02, 2026David LarsenBTIG$11.00$7.0755.59%65.66%
Jan 08, 2026Steve DechertKeyBanc$8.50$7.3016.44%28.01%
Jan 08, 2026Richard CloseCanaccord Genuity$9.00$7.3023.29%35.54%
Dec 12, 2025BTIG$10.00$6.7747.71%50.60%
Dec 08, 2025Peter WarendorfBarclays$8.00$6.4124.80%20.48%
May 27, 2025Kevin CaliendoUBS$8.50$6.0640.26%28.01%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 25, 2026BMO CapitalOutperformOutperformhold
Feb 02, 2026BTIGBuyBuyhold
Jan 08, 2026KeyBancOverweightOverweighthold
Dec 12, 2025BTIGBuyBuyhold
Dec 08, 2025BarclaysOverweightinitialise
May 27, 2025UBSBuyupgrade
Dec 16, 2024Goldman SachsNeutralBuyupgrade
Feb 28, 2024William BlairOutperformOutperformhold
Nov 22, 2023Goldman SachsNeutralNeutralhold
Jan 06, 2023Morgan StanleyOverweightupgrade

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-1.05$-0.61$-0.51$-0.15$0.03-
Avg Forecast$-0.87$-0.61$-0.48$-0.17$-0.13$-0.02
High Forecast$-0.85$-0.60$-0.46$-0.16$-0.08$0.01
Low Forecast$-0.89$-0.61$-0.49$-0.17$-0.18$-0.05
Surprise %20.69%-6.25%-11.76%-123.08%-

Revenue Forecast

$650M $840M $1B $1B $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$667.51M$859.54M$1.06B$1.25B$1.42B-
Avg Forecast$668.47M$846.42M$1.04B$1.24B$1.39B$1.58B
High Forecast$678.78M$854.68M$1.05B$1.25B$1.41B$1.58B
Low Forecast$658.91M$837.73M$1.03B$1.23B$1.38B$1.58B
Surprise %-0.14%1.55%1.74%0.95%2.59%-

Net Income Forecast

$-350M $-270M $-190M $-110M $-30M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-307.20M$-215.56M$-186.26M$-57.44M$9.66M-
Avg Forecast$-319.77M$-222.68M$-175.90M$-61.60M$-54.26M$-7.77M
High Forecast$-313.82M$-219.71M$-170.23M$-60.24M$-30.90M$2.03M
Low Forecast$-326.18M$-225.50M$-181.58M$-62.97M$-65.24M$-17.57M
Surprise %-3.93%-3.20%5.89%-6.75%-117.81%-

LFST Forecast FAQ

Is LifeStance Health Group stock a buy?

LifeStance Health Group stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LifeStance Health Group is a favorable investment for most analysts.

What is LifeStance Health Group's price target?

LifeStance Health Group's price target, set by 11 Wall Street analysts, averages $9.3 over the next 12 months. The price target range spans from $8 at the low end to $11 at the high end, suggesting a potential 40.06% change from the previous closing price of $6.64.

How does LifeStance Health Group stock forecast compare to its benchmarks?

LifeStance Health Group's stock forecast shows a 40.06% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (19.55%).

What is the breakdown of analyst ratings for LifeStance Health Group over the past three months?

  • March 2026: 20.00% Strong Buy, 70.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 20.00% Strong Buy, 70.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 20.00% Strong Buy, 70.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.

What is LifeStance Health Group’s EPS forecast?

LifeStance Health Group's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.02, marking a -166.67% decrease from the reported $0.03 in 2025..

What is LifeStance Health Group’s revenue forecast?

LifeStance Health Group's average annual revenue forecast for its fiscal year ending in December 2026 is $1.58B, reflecting a 11.12% increase from the reported $1.42B in 2025.

What is LifeStance Health Group’s net income forecast?

LifeStance Health Group's net income forecast for the fiscal year ending in December 2026 stands at $-7.77M, representing a -180.41% decrease from the reported $9.66M in 2025.